Skip to main content
. 2019 Jul 3;31(3):287–291. doi: 10.1016/j.joco.2019.06.001

Table 2.

Superficial and deep capillary plexus (DCP) vascular density at baseline and following panretinal photocoagulation (PRP) at various Early Treatment Diabetic Retinopathy Study (ETDRS) circles.

Baseline After PRP P valuea
FAZ 0.40 ± 0.13 0.39 ± 0.13 0.75
SCP vascular density (%) Fovea 24.5 ± 4.7 26.0 ± 3.3 0.007
Para-Fovea 47.2 ± 3.8 47.6 ± 4.6 0.80
Temporal 47.4 ± 3.5 46.1 ± 6.1 0.55
Nasal 45.0 ± 6.8 47.5 ± 4.7 0.31
Superior 48.4 ± 5.1 48.5 ± 4.5 0.95
Inferior 46.9 ± 4.7 48.4 ± 4.8 0.35
DCP vascular density (%) Fovea 22.8 ± 7.2 26.1 ± 4.9 0.03
Para-Fovea 53.8 ± 2.1 53.5 ± 3.2 0.79
Temporal 50.8 ± 5.6 54.3 ± 2.8 0.049
Nasal 51.6 ± 5.4 53.5 ± 2.8 0.27
Superior 56.0 ± 2.3 55.3 ± 3.7 0.62
Inferior 54.5 ± 3.8 54.4 ± 4.1 0.85

PRP: Panretinal photocoagulation; FAZ: Foveal avascular zone measure at superficial capillary plexus; SCP: Superficial capillary plexus; DCP: Deep capillary plexus.

a

By generalized estimating equation (GEE) model.